🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 2 study aims to assess the efficacy of SC injections of STP705 f...
Status
Recruiting
Location
Emeritus Research Sydney
Start Date
2026-07-28
Trial ID
NCT07677683
Treatments Being Tested
Adult patients with hypertrophic scars 30 Subjects in Dose Escalation 20 Su...
Status
Withdrawn
Location
The 9th Hospital of Shanghai
Start Date
2021-12-07
Trial ID
NCT05196373
Treatments Being Tested
This is a randomized, double-blind, within-subject placebo controlled study...
Status
Completed
Location
WCCT Global
Start Date
2017-01
Trial ID
NCT02956317
Dose-ranging, randomized, double-blind, vehicle-controlled study...
Status
Completed
Location
Center for Clinical and Cosmetic Research
Start Date
2022-08-01
Trial ID
NCT05422378
Treatments Being Tested
Open label, dose escalation to evaluate safety....
Status
Completed
Location
Center for Clinical and Cosmetic Research
Start Date
2022-08-01
Trial ID
NCT05421013
Treatments Being Tested
The purpose of this trial is to evaluate safety, tolerability and efficacy ...
Status
Completed
Location
Investigate MD
Start Date
2021-05-18
Trial ID
NCT04844983
Treatments Being Tested
This is an open label, dose escalation study to evaluate the safety and eff...
Status
Completed
Location
Center for Clinical and Cosmetic Research
Start Date
2019-03-21
Trial ID
NCT04293679
Treatments Being Tested
Phase 2, randomized, double-blind, multiple arm, controlled study to evalua...
Status
Completed
Location
Investigate MD
Start Date
2021-04-29
Trial ID
NCT04844840
This phase 2, open label, dose escalation study is designed to evaluate the...
Status
Completed
Location
Center for Clinical and Cosmetic Research
Start Date
2020-12-28
Trial ID
NCT04669808
Treatments Being Tested
This is an open label, dose escalation and dose expansion study to evaluate...
Status
Completed
Location
Honor Health
Start Date
2021-03-01
Trial ID
NCT04676633
Treatments Being Tested